{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:15:01Z","timestamp":1783149301532,"version":"3.54.6"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["13060103"],"award-info":[{"award-number":["13060103"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["SCR_026668"],"award-info":[{"award-number":["SCR_026668"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110018","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:42:18Z","timestamp":1779428538000},"page":"110018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Antineoplastic multi-targeted spiro[indoline-3,2\u2032-pyrrolidines] incorporating urea function: Rational design, synthesis and bio-properties studies"],"prefix":"10.1016","volume":"179","author":[{"given":"Nehmedo G.","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva S.","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Bekheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.F.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel S.","family":"Girgis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110018_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500447","article-title":"Recent insights in multi-target drugs in pharmacology and medicinal chemistry","volume":"20","author":"Cemali","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110018_bb0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cbpa.2020.05.009","article-title":"Two-hit wonders: the expanding universe of multitargeting epigenetic agents","volume":"57","author":"de Lera","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110018_bb0015","doi-asserted-by":"crossref","first-page":"48887","DOI":"10.1021\/acsomega.5c07084","article-title":"Silodosin as a novel inhibitor of acetylcholinesterase, butyrylcholinesterase, and beta-secretase 1: in vitro and in silico studies","volume":"10","author":"Barbosa","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110018_bb0020","doi-asserted-by":"crossref","first-page":"40363","DOI":"10.1038\/s41598-025-25796-6","article-title":"Antineoplastic 4-piperidone-1-phosphonothioates with potential multi-targeted inhibitory properties","volume":"15","author":"Bekheit","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110018_bb0025","doi-asserted-by":"crossref","first-page":"46935","DOI":"10.1021\/acsomega.5c05103","article-title":"Design, synthesis, in vitro evaluation, multitargeted molecular docking, and in silico analysis of some azo-linked 1,3,4-thiadiazole and 1,2,4-triazole heterocyclic hybrids as potent antitubercular agents","volume":"10","author":"Panigrahi","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110018_bb0030","doi-asserted-by":"crossref","first-page":"20450","DOI":"10.1039\/C9RA03380G","article-title":"Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid\u2013isoniazid hybrid conjugates","volume":"9","author":"Panda","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110018_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.128421","article-title":"Multitarget inhibition of diabetic enzymes by thiazole carboxylic acids: experimental and computational approaches","volume":"437","author":"Gerni","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioorg.2026.110018_bb0040","doi-asserted-by":"crossref","first-page":"33712","DOI":"10.1021\/acsomega.5c04663","article-title":"Synthesis and in vitro biological evaluation of quinolone-based hydrazones as potential antidiabetic agents targeting key metabolic enzymes","volume":"10","author":"Pravin","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110018_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118258","article-title":"Synthesis and multitarget inhibitory effect of indole-based ethyl cinnamate derivatives against SARS-CoV-2 Mpro and cathepsins for broad-spectrum anti-coronavirus activity","volume":"128","author":"Citarella","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115292","article-title":"Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2","volume":"252","author":"Bekheit","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105466","article-title":"Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties","volume":"117","author":"Srour","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0060","article-title":"Design, synthesis, and biological evaluation of new tetrahydropyrimidine derivatives as multitarget anti-inflammatory agents","volume":"13","author":"Ali","year":"2025","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.bioorg.2026.110018_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500342","article-title":"Hybrid conjugates of ibuprofen and 3,5-diarylidene-4-piperidone: a new avenue in anti-inflammatory drug discovery","volume":"20","author":"Chavez","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110018_bb0070","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.bmcl.2015.04.023","article-title":"Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates","volume":"25","author":"Naumov","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110018_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118370","article-title":"Hybrid molecules of ibuprofen and piperidone: a rational approach toward anti-cancer drug development","volume":"130","author":"Panda","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0080","doi-asserted-by":"crossref","first-page":"28554","DOI":"10.1039\/C4RA16663A","article-title":"Rational design, synthesis, and 2D-QSAR study of anti-oncological alkaloids against hepatoma and cervical carcinoma","volume":"5","author":"Girgis","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110018_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118369","article-title":"Targeting Alzheimer\u2019s pathology: tetralone- and thiochromanone-based benzyl pyridinium derivatives as promising multi-target-directed ligands","volume":"130","author":"Sobha","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0090","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.3390\/molecules30173489","article-title":"Multifunctional tacrine\u2013quinoline hybrids as cholinesterase inhibitors, a\u03b2 aggregation blockers, and metal chelators for Alzheimer\u2019s therapy","volume":"30","author":"Wang","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110018_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118219","article-title":"Dual inhibitors of butyrylcholinesterase and histone deacetylase 6 for the treatment of Alzheimer\u2019s disease: design, synthesis, and biological evaluation","volume":"127","author":"Lv","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/ph18020274","article-title":"The therapeutic potential of spirooxindoles in cancer: a focus on p53\u2013MDM2 modulation","volume":"18","author":"Girgis","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.110018_bb0105","doi-asserted-by":"crossref","first-page":"10486","DOI":"10.1021\/jm501541j","article-title":"Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-Mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles","volume":"57","author":"Aguilar","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114334","article-title":"Small-molecule MDM2 inhibitors in clinical trials for cancer therapy","volume":"236","author":"Wang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12929-024-01004-x","article-title":"Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy","volume":"31","author":"Sun","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bioorg.2026.110018_bb0120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.apsb.2020.01.003","article-title":"Small-molecule MDM2\/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives","volume":"10","author":"Fang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2026.110018_bb0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2019.05.018","article-title":"The past, present and future of potential small-molecule drugs targeting p53-MDM2\/MDMX for cancer therapy","volume":"176","author":"Liu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104507","article-title":"Synthesis, antidiabetic activity and molecular docking study of Rhodanine-substitued Spirooxindole Pyrrolidine derivatives as novel \u03b1-amylase inhibitors","volume":"106","author":"Toumi","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104798","article-title":"Stereoselective synthesis and discovery of novel spirooxindolopyrrolidine engrafted indandione heterocyclic hybrids as antimycobacterial agents","volume":"110","author":"Arumugam","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115563","article-title":"Spiroindole-containing compounds bearing phosphonate group of potential Mpro-SARS-CoV-2 inhibitory properties","volume":"258","author":"Bekheit","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0145","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bioorg.2017.09.019","article-title":"Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines","volume":"75","author":"Basiri","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0150","doi-asserted-by":"crossref","first-page":"13880","DOI":"10.1038\/s41598-022-17883-9","article-title":"Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties","volume":"12","author":"Fawazy","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110018_bb0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11030-013-9498-y","article-title":"A regioselective multicomponent protocol for the synthesis of novel bioactive 4-hydroxyquinolin-2(1H)-one grafted monospiropyrrolidine and thiapyrrolizidine hybrids","volume":"18","author":"Sankaran","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2026.110018_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105011","article-title":"The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015\u20132020","volume":"113","author":"Liang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116534","article-title":"How the structural properties of the indole derivatives are important in kinase targeted drug design?: A case study on tyrosine kinase inhibitors","volume":"53","author":"Mondal","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0180","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.110018_bb0185","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/13543776.2021.1935872","article-title":"An updated patent review of VEGFR-2 inhibitors (2017-present)","volume":"31","author":"Farghaly","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2026.110018_bb0220","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0040-4020(01)00020-5","article-title":"Regioselective synthetic approaches towards 1,2,8,9-tetraazadispiro[4.1.4.3]tetradeca-2,9-dien-6-ones","volume":"57","author":"Girgis","year":"2001","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2026.110018_bb0225","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1021\/jm058208o","article-title":"Synthesis and evaluation of new antimalarial Phenylurenyl chalcone derivatives","volume":"48","author":"Dom\u00ednguez","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000334","article-title":"Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea","volume":"354","author":"Gezegen","year":"2021","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2026.110018_bb0235","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2174\/1570180819666220110153542","article-title":"Synthesis and studies of anticancer and antimicrobial activity of new phenylurenyl chalcone derivatives","volume":"19","author":"Akdeniz","year":"2022","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.bioorg.2026.110018_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105038","article-title":"Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity","volume":"114","author":"Tok","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2025.118101","article-title":"Idarubicin-labeled electrochemical biosensor for detection of circulating tumor cells in colon cancer patients","volume":"292","author":"Saputra","year":"2026","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bioorg.2026.110018_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.131759","article-title":"Protective effects of non-extractable phenolics from strawberry against inflammation and colon cancer in vitro","volume":"374","author":"Huang","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116553","article-title":"Altered gut metabolites and metabolic reprogramming involved in the pathogenesis of colitis-associated colorectal cancer and the transition of colon \"inflammation to cancer\"","volume":"253","author":"Wang","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2026.110018_bb0280","article-title":"Diagnostic innovations and therapeutic potential of nanoparticulate delivery for colon cancer","volume":"41","author":"Roy","year":"2025","journal-title":"Nano-Struct. Nano-Objects"},{"key":"10.1016\/j.bioorg.2026.110018_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2025.106804","article-title":"Recent advances in the encapsulation of probiotics as functional foods for colorectal cancer prevention","volume":"128","author":"Gan","year":"2025","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bioorg.2026.110018_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2025.109084","article-title":"Facile synthesis of highly active PtSnCoNi hierarchical dendritic nanowires greatly boosting signal amplification for ultrasensitive immunoassay of biomarker HER-2","volume":"168","author":"Shi","year":"2026","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.bioorg.2026.110018_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2025.116114","article-title":"Exploring lipotoxicity-related prognostic genes and experimental validation in breast cancer using electrochemical sensors and single-cell transcriptomics analysis","volume":"219","author":"Fu","year":"2025","journal-title":"Microchem. J."},{"key":"10.1016\/j.bioorg.2026.110018_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111451","article-title":"Advances in combination therapy for the treatment of estrogen receptor positive breast cancer","volume":"36","author":"Liu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110018_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102741","article-title":"Biochemical and anticancer properties of Stellaria media extract in breast Cancer","volume":"18","author":"Eftekhari","year":"2025","journal-title":"Results Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bioorg.2026.110018_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2025.08.039","article-title":"Skin cancer segmentation and recognition from dermoscopy images: a novel framework based on improved DeepLabV3+ and network-level fused deep architectures","author":"Arshad","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2026.110018_bb0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jare.2021.06.014","article-title":"Skin cancer biology and barriers to treatment: recent applications of polymeric micro\/nanostructures","volume":"36","author":"Khan","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2026.110018_bb0325","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jare.2024.01.013","article-title":"Targeting tumor-associated macrophages: novel insights into immunotherapy of skin cancer","volume":"67","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2026.110018_bb0345","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1021\/acschembio.9b00338","article-title":"Procaspase-3 overexpression in cancer: a paradoxical observation with therapeutic potential","volume":"14","author":"Boudreau","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110018_bb0350","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ijc.31374","article-title":"Caspase-3 regulates the migration, invasion, and metastasis of colon cancer cells","volume":"143","author":"Zhou","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110018_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2025.110687","article-title":"A newly identified homolog of scallop caspase-3\/7 plays a pivotal role in the immunological response and orchestrates the induction of apoptosis","volume":"167","author":"Cui","year":"2025","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.bioorg.2026.110018_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118464","article-title":"Discovery of \u03b1-carboline fused benzofuran-containing anticancer agents as rapid apoptosis inducers through intrinsic pathway","volume":"303","author":"Lin","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0370","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/med.21379","article-title":"Direct activation of Bax protein for cancer therapy","volume":"36","author":"Liu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2026.110018_bb0380","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2007-09-078162","article-title":"Bcl-2\u2013family proteins and hematologic malignancies: history and future prospects","volume":"111","author":"Reed","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bioorg.2026.110018_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120567","article-title":"Technologic advances in flow cytometry","volume":"578","author":"Liu","year":"2026","journal-title":"Clin. Chim. Acta"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110018_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjac.2025.100558","article-title":"Development of recombinant anti-human CD antibodies for diabetes and cancer monitoring using flow cytometry","volume":"53","author":"Yang","year":"2025","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.semdp.2025.150942","article-title":"Flow cytometry in the diagnosis and prognosis of multiple myeloma","volume":"42","author":"Seegmiller","year":"2025","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.bioorg.2026.110018_bb0405","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrm3629","article-title":"Control of cell cycle transcription during G1 and S phases","volume":"14","author":"Bertoli","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110018_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200164","article-title":"Development of isatin-based Schiff bases targeting VEGFR-2 inhibition: synthesis, characterization, antiproliferative properties, and QSAR studies","volume":"17","author":"Seliem","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110018_bb0425","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1538\/expanim.14-0059","article-title":"Chick embryo chorioallantoic membrane (CAM): an alternative predictive model in acute toxicological studies for anti-cancer drugs","volume":"64","author":"Kue","year":"2015","journal-title":"Exp. Anim."},{"key":"10.1016\/j.bioorg.2026.110018_bb0430","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2014.03.045","article-title":"6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity","volume":"78","author":"Kim","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0435","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cclet.2015.10.004","article-title":"Design, synthesis and biological evaluation of biphenylurea derivatives as VEGFR-2 kinase inhibitors (II)","volume":"27","author":"Gao","year":"2016","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110018_bb0440","series-title":"Chick Chorioallantoic Membrane (CAM) Angiogenesis Assay","year":"2026"},{"key":"10.1016\/j.bioorg.2026.110018_bb0445","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/pharmaceutics15010049","article-title":"A guide to in silico drug design","volume":"15","author":"Chang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.110018_bb0450","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2026.110018_bb0460","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-85588-w","article-title":"Curcumin mimics of potential chemoprevention with NQO1 induction properties","volume":"15","author":"Aboshouk","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.110018_bb0465","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0470","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejmech.2014.08.004","article-title":"Molecular dynamics in drug design","volume":"91","author":"Zhao","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110018_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103666","article-title":"A new class of 1,3,5-triazine-based selective estrogen receptor degraders (SERDs): Lead optimization, molecular docking and dynamic simulation","volume":"97","author":"Lu","year":"2020","journal-title":"Bioorg. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826005547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:15:45Z","timestamp":1783145745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826005547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":74,"alternative-id":["S0045206826005547"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110018","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antineoplastic multi-targeted spiro[indoline-3,2\u2032-pyrrolidines] incorporating urea function: Rational design, synthesis and bio-properties studies","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110018"}}